Skip to main content
Erschienen in: Rheumatology International 3/2011

01.03.2011 | Original Article

Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura

verfasst von: Tao Chen, Zai-pei Guo, Yu-hong Zhang, Ying Gao, Hong-jie Liu, Jing-yi Li

Erschienen in: Rheumatology International | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to investigate the levels of heme oxygenase-1 (HO-1), insulin-like growth factor-1 (IGF-1) and oxidative stress parameters including malondialdehyde (MDA), total antioxidant capacity (T-AOC) and the activities of total superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), catalase (CAT) for exploring the correlations between these biological indexes and the clinical manifestations in Henoch-Schonlein purpura (HSP) patients. 36 patients with different phases of HSP and 16 age- and sex-matched controls were enrolled. MDA level, T-AOC and the activities of SOD, GSH-PX and CAT were measured by spectrophotometry. HO-1 and IGF-1 levels were detected by enzyme-linked immunosorbent assay. Significant higher MDA level, lower T-AOC, SOD, GSH-PX activities were shown in active phase of HSP, respectively, compared with those in early resolution phase of HSP (p < 0.001, <0.001, 0.017, <0.001, respectively) and the control subjects (p < 0.001, <0.001, 0.01, 0.008, respectively). HO-1 (both p < 0.001) and IGF-1 (p < 0.001, 0.009, respectively) levels in active phase and early resolution phase of HSP were significantly higher than those in normal controls. The changes of HO-1 and IGF-1 levels were coincident with overall clinical scores (r = 0.71, p < 0.001; r = 0.615, p < 0.001, respectively). The HO-1 level was found as positive correlation with MDA levels (r = 0.395, p = 0.017), but negative correlations with T-AOC (r = −0.409, p = 0.013) and SOD activities (r = −0.352, p = 0.035). HO-1 and IGF-1 were possibly involved in the pathogenesis of HSP; they could be the marker for evaluating the severity of the disease.
Literatur
1.
Zurück zum Zitat Egan CA, Taylor TB, Meyer LJ, Petersen MJ, Zone JJ (1999) IgA1 is the major IgA subclass in cutaneous blood vessels in Henoch-Schönlein purpura. Br J Dermatol 141:859–862CrossRefPubMed Egan CA, Taylor TB, Meyer LJ, Petersen MJ, Zone JJ (1999) IgA1 is the major IgA subclass in cutaneous blood vessels in Henoch-Schönlein purpura. Br J Dermatol 141:859–862CrossRefPubMed
2.
Zurück zum Zitat Kawakami T, Watabe H, Mizoguchi M, Soma Y (2006) Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura. Br J Dermatol 155:983–987CrossRefPubMed Kawakami T, Watabe H, Mizoguchi M, Soma Y (2006) Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura. Br J Dermatol 155:983–987CrossRefPubMed
3.
Zurück zum Zitat Pawlak K, Naumnik B, Brzósko S, Pawlak D, Myśliwiec M (2004) Oxidative stress—a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients. Am J Nephrol 24:154–161CrossRefPubMed Pawlak K, Naumnik B, Brzósko S, Pawlak D, Myśliwiec M (2004) Oxidative stress—a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients. Am J Nephrol 24:154–161CrossRefPubMed
4.
Zurück zum Zitat Manning RD Jr, Meng S, Tian N (2003) Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 179:243–250CrossRefPubMed Manning RD Jr, Meng S, Tian N (2003) Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 179:243–250CrossRefPubMed
5.
Zurück zum Zitat Ece A, Kelekçi S, Kocamaz H, Hekimoğlu A, Balik H, Yolbaş I et al (2008) Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura. Clin Rheumatol 27:163–169CrossRefPubMed Ece A, Kelekçi S, Kocamaz H, Hekimoğlu A, Balik H, Yolbaş I et al (2008) Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura. Clin Rheumatol 27:163–169CrossRefPubMed
6.
Zurück zum Zitat Janero DR (1990) Malondialdehyde and thiobarbituric-acid reactivity as diagnostic indices of lipid peroxidation, and peroxidative tissue injury. Free Radic Biol Med 9:515–540CrossRefPubMed Janero DR (1990) Malondialdehyde and thiobarbituric-acid reactivity as diagnostic indices of lipid peroxidation, and peroxidative tissue injury. Free Radic Biol Med 9:515–540CrossRefPubMed
7.
Zurück zum Zitat Maxwell SR, Dietrich T, Chapple IL (2006) Prediction of serum total antioxidant activity from the concentration of individual serum antioxidants. Clin Chim Acta 372:188–194CrossRefPubMed Maxwell SR, Dietrich T, Chapple IL (2006) Prediction of serum total antioxidant activity from the concentration of individual serum antioxidants. Clin Chim Acta 372:188–194CrossRefPubMed
8.
Zurück zum Zitat Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Yet Li et al (2007) IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 27:2684–2690CrossRefPubMed Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Yet Li et al (2007) IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 27:2684–2690CrossRefPubMed
9.
Zurück zum Zitat Csiszar A, Labinskyy N, Perez V, Recchia FA, Podlutsky A, Mukhopadhyay P et al (2008) Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol 295:1882–1894CrossRef Csiszar A, Labinskyy N, Perez V, Recchia FA, Podlutsky A, Mukhopadhyay P et al (2008) Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol 295:1882–1894CrossRef
10.
Zurück zum Zitat Wilson SJ, Keenan AK (2003) Role of hemin in the modulation of H2O2-mediated endothelial cell injury. Vascul Pharmacol 40:109–118CrossRefPubMed Wilson SJ, Keenan AK (2003) Role of hemin in the modulation of H2O2-mediated endothelial cell injury. Vascul Pharmacol 40:109–118CrossRefPubMed
11.
Zurück zum Zitat True AL, Olive M, Boehm M, San H, Westrick RJ, Raghavachari N et al (2007) Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 101:893–901CrossRefPubMed True AL, Olive M, Boehm M, San H, Westrick RJ, Raghavachari N et al (2007) Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 101:893–901CrossRefPubMed
12.
Zurück zum Zitat Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY (1998) Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152:711–720PubMed Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY (1998) Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152:711–720PubMed
13.
Zurück zum Zitat Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M et al (2001) Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104:1831–1836CrossRefPubMed Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M et al (2001) Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104:1831–1836CrossRefPubMed
14.
Zurück zum Zitat Ishikawa K, Sugawara D, Wang XP, Suzuki K, Itabe H, Maruyama Y et al (2001) Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circ Res 88:506–512PubMed Ishikawa K, Sugawara D, Wang XP, Suzuki K, Itabe H, Maruyama Y et al (2001) Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circ Res 88:506–512PubMed
15.
Zurück zum Zitat Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T (2002) Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case–control study. Circulation 106:939–944CrossRefPubMed Juul A, Scheike T, Davidsen M, Gyllenborg J, Jørgensen T (2002) Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case–control study. Circulation 106:939–944CrossRefPubMed
16.
Zurück zum Zitat Späh F (2008) Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 159:10–17CrossRefPubMed Späh F (2008) Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 159:10–17CrossRefPubMed
17.
Zurück zum Zitat Wu SH, Liao PY, Yin PL, Zhang YM, Dong L (2009) Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch-Schönlein purpura. Prostaglandins Leukot Essent Fatty Acids 80:177–183CrossRefPubMed Wu SH, Liao PY, Yin PL, Zhang YM, Dong L (2009) Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch-Schönlein purpura. Prostaglandins Leukot Essent Fatty Acids 80:177–183CrossRefPubMed
18.
Zurück zum Zitat Yildiz B, Kural N, Aydin B, Colak O (2008) Increased serum levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3 in Henoch-Schonlein purpura. Tohoku J Exp Med 214:333–340CrossRefPubMed Yildiz B, Kural N, Aydin B, Colak O (2008) Increased serum levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3 in Henoch-Schonlein purpura. Tohoku J Exp Med 214:333–340CrossRefPubMed
19.
Zurück zum Zitat Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 33:1114–1121CrossRefPubMed Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 33:1114–1121CrossRefPubMed
20.
Zurück zum Zitat Huang DC, Yang YH, Lin YT, Chiang BL (2003) Cyclosporin A therapy for steroid-dependent Henoch-Schönlein purpura. J Microbiol Immunol Infect 36:61–64PubMed Huang DC, Yang YH, Lin YT, Chiang BL (2003) Cyclosporin A therapy for steroid-dependent Henoch-Schönlein purpura. J Microbiol Immunol Infect 36:61–64PubMed
21.
Zurück zum Zitat Fessatou S, Nicolaidou P, Gourgiotis D, Georgouli H, Douros K, Moustaki M et al (2008) Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura. BMC Pediatr 8:33CrossRefPubMed Fessatou S, Nicolaidou P, Gourgiotis D, Georgouli H, Douros K, Moustaki M et al (2008) Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura. BMC Pediatr 8:33CrossRefPubMed
22.
Zurück zum Zitat Yang YH, Wang SJ, Chuang YH, Lin YT, Chiang BL (2002) The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Schönlein purpura. Clin Exp Immunol 130:352–357CrossRefPubMed Yang YH, Wang SJ, Chuang YH, Lin YT, Chiang BL (2002) The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Schönlein purpura. Clin Exp Immunol 130:352–357CrossRefPubMed
23.
Zurück zum Zitat Buyan N, Erbaş D, Akkök N, Oz E, Biberoğlu G, Hasanoğlu E (1998) Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch-Schönlein Purpura. Prostaglandins Leukot Essent Fatty Acids 59:181–184CrossRefPubMed Buyan N, Erbaş D, Akkök N, Oz E, Biberoğlu G, Hasanoğlu E (1998) Role of free oxygen radicals and prostanoids in the pathogenesis of Henoch-Schönlein Purpura. Prostaglandins Leukot Essent Fatty Acids 59:181–184CrossRefPubMed
24.
Zurück zum Zitat Erdoğan O, Oner A, Aydin A, Işimer A, Demircin G, Bülbül M (2003) Effect of vitamin E treatment on the oxidative damage occurring in Henoch-Schönlein purpura. Acta Paediatr 92:546–550CrossRefPubMed Erdoğan O, Oner A, Aydin A, Işimer A, Demircin G, Bülbül M (2003) Effect of vitamin E treatment on the oxidative damage occurring in Henoch-Schönlein purpura. Acta Paediatr 92:546–550CrossRefPubMed
25.
Zurück zum Zitat Huang Y, Wu L, Xu C, XuYang B, Wang R (2006) Increased HO-1 expression and decreased iNOS expression in the hippocampus from adult spontaneously hypertensive rats. Cell Biochem Biophys 46:35–42CrossRefPubMed Huang Y, Wu L, Xu C, XuYang B, Wang R (2006) Increased HO-1 expression and decreased iNOS expression in the hippocampus from adult spontaneously hypertensive rats. Cell Biochem Biophys 46:35–42CrossRefPubMed
26.
Zurück zum Zitat Kirino Y, Takeno M, Iwasaki M, Ueda A, Ohno S, Shirai A et al (2005) Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still’s disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther 7:616–624CrossRef Kirino Y, Takeno M, Iwasaki M, Ueda A, Ohno S, Shirai A et al (2005) Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still’s disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther 7:616–624CrossRef
27.
Zurück zum Zitat Carraway MS, Ghio AJ, Taylor JL, Piantadosi CA (1998) Induction of ferritin and heme oxygenase-1 by endotoxin in the lung. Am J Physiol 275:L583–L592PubMed Carraway MS, Ghio AJ, Taylor JL, Piantadosi CA (1998) Induction of ferritin and heme oxygenase-1 by endotoxin in the lung. Am J Physiol 275:L583–L592PubMed
28.
Zurück zum Zitat Panchenko MV, Farber HW, Korn JH (2000) Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts. Am J Physiol Cell Physiol 278:C92–C101PubMed Panchenko MV, Farber HW, Korn JH (2000) Induction of heme oxygenase-1 by hypoxia and free radicals in human dermal fibroblasts. Am J Physiol Cell Physiol 278:C92–C101PubMed
29.
Zurück zum Zitat Yakar S, Liu JL, Le Roith D (2000) The growth hormone/insulin-like growth factor-I system: implications for organ growth and development. Pediatr Nephrol 14:544–549CrossRefPubMed Yakar S, Liu JL, Le Roith D (2000) The growth hormone/insulin-like growth factor-I system: implications for organ growth and development. Pediatr Nephrol 14:544–549CrossRefPubMed
30.
Zurück zum Zitat Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C et al (2004) Insulin-like growth factor-1 as a vascular protective factor. Circulation 110:2260–2265CrossRefPubMed Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C et al (2004) Insulin-like growth factor-1 as a vascular protective factor. Circulation 110:2260–2265CrossRefPubMed
31.
Zurück zum Zitat Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S (2008) Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis. J Rheumatol 35:2363–2371CrossRefPubMed Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S (2008) Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis. J Rheumatol 35:2363–2371CrossRefPubMed
32.
Zurück zum Zitat Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C et al (2006) Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203:1117–1127CrossRefPubMed Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C et al (2006) Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203:1117–1127CrossRefPubMed
33.
Zurück zum Zitat Hsu M, Muchova L, Morioka I, Wong RJ, Schröder H, Stevenson DK (2006) Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun 343:738–744CrossRefPubMed Hsu M, Muchova L, Morioka I, Wong RJ, Schröder H, Stevenson DK (2006) Tissue-specific effects of statins on the expression of heme oxygenase-1 in vivo. Biochem Biophys Res Commun 343:738–744CrossRefPubMed
34.
Zurück zum Zitat Grosser N, Hemmerle A, Berndt G, Erdmann K, Hinkelmann U, Schürger S et al (2004) The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med 37:2064–2071CrossRefPubMed Grosser N, Hemmerle A, Berndt G, Erdmann K, Hinkelmann U, Schürger S et al (2004) The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med 37:2064–2071CrossRefPubMed
35.
Zurück zum Zitat Conti E, Musumeci MB, Assenza GE, Quarta G, Autore C, Volpe M (2008) Recombinant human insulin-like growth factor-1: a new cardiovascular disease treatment option? Cardiovasc Hematol Agents Med Chem 6:258–271CrossRefPubMed Conti E, Musumeci MB, Assenza GE, Quarta G, Autore C, Volpe M (2008) Recombinant human insulin-like growth factor-1: a new cardiovascular disease treatment option? Cardiovasc Hematol Agents Med Chem 6:258–271CrossRefPubMed
Metadaten
Titel
Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura
verfasst von
Tao Chen
Zai-pei Guo
Yu-hong Zhang
Ying Gao
Hong-jie Liu
Jing-yi Li
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 3/2011
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1254-3

Weitere Artikel der Ausgabe 3/2011

Rheumatology International 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.